Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
VAPOR-C is a randomised study of the impact of IV versus inhaled anaesthesia (propofol versus
sevoflurane) and lidocaine versus placebo on duration of disease free survival inpatients
with either colorectal or non small cell lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Peter MacCallum Cancer Centre, Australia
Collaborators:
National Health & Medical Research Council of Australia (NH&MRC) The Australian and New Zealand College of Anaesthetists (ANZCA) Victorian Comprehensive Cancer Centre